• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子编码异常粪便免疫化学检测与结肠镜检查完成率增加相关。

Electronic Coding for Abnormal Fecal Immunochemical Test Is Associated With Increased Colonoscopy Completion.

机构信息

Department of Medicine, University of California, San Francisco, California, USA.

Division of Gastroenterology, University of California San Francisco.

出版信息

Am J Gastroenterol. 2024 Jul 1;119(7):1431-1432. doi: 10.14309/ajg.0000000000002754. Epub 2024 Mar 15.

DOI:10.14309/ajg.0000000000002754
PMID:38488169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11686599/
Abstract

INTRODUCTION

We examined the utility of the International Classification of Disease, Tenth Revision (ICD-10) code, R19.5, for a positive or abnormal fecal immunochemical test (FIT) and its association with colonoscopy completion.

METHODS

We identified all patients in a safety-net health system who underwent FITs from January 1, 2020, to August 31, 2021, and extracted the FIT date, FIT result, and ICD-10 code (R19.5) and colonoscopy procedures for each patient.

RESULTS

FIT-positive patients who had an R19.5 designation within 90 days (n = 383) were significantly more likely than all other FIT-positive patients (n = 273) to complete a colonoscopy within 6 months (40.9% vs 16.8%, P <0.001).

DISCUSSION

We found that less than two-thirds of patients had an ICD-10 code designated in their chart within 30 days of an abnormal FIT. When coding occurred in a timely manner, patients were more likely to complete their colonoscopy within 6 months.

摘要

简介

我们研究了国际疾病分类第 10 版(ICD-10)代码 R19.5 对粪便免疫化学检测(FIT)阳性或异常的效用及其与结肠镜检查完成情况的关系。

方法

我们在一个安全网医疗系统中确定了所有在 2020 年 1 月 1 日至 2021 年 8 月 31 日期间接受 FIT 的患者,并提取每位患者的 FIT 日期、FIT 结果和 ICD-10 代码(R19.5)和结肠镜检查程序。

结果

在 90 天内(n=383)有 R19.5 诊断的 FIT 阳性患者,比所有其他 FIT 阳性患者(n=273)在 6 个月内完成结肠镜检查的可能性显著更高(40.9% vs 16.8%,P<0.001)。

讨论

我们发现,不到三分之二的患者在异常 FIT 后 30 天内其图表中就有 ICD-10 代码指定。当及时编码时,患者更有可能在 6 个月内完成结肠镜检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debb/11686599/8ed9949931b3/nihms-2043945-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debb/11686599/8ed9949931b3/nihms-2043945-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/debb/11686599/8ed9949931b3/nihms-2043945-f0001.jpg

相似文献

1
Electronic Coding for Abnormal Fecal Immunochemical Test Is Associated With Increased Colonoscopy Completion.电子编码异常粪便免疫化学检测与结肠镜检查完成率增加相关。
Am J Gastroenterol. 2024 Jul 1;119(7):1431-1432. doi: 10.14309/ajg.0000000000002754. Epub 2024 Mar 15.
2
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.基于愈创木脂的粪便潜血试验与粪便免疫化学试验用于一般风险人群结直肠癌筛查。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2.
3
The Impact of Follow-up Colonoscopy on Survival in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program: A Nationwide Study.基于粪便免疫化学检测的结直肠癌筛查项目中结肠镜随访对生存的影响:一项全国性研究
Dis Colon Rectum. 2025 Jul 1;68(7):899-906. doi: 10.1097/DCR.0000000000003771. Epub 2025 Apr 9.
4
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.多靶点粪便免疫化学试验与粪便免疫化学试验用于结直肠癌筛查项目:一项具有配对设计的横断面干预研究。
BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.
5
Mailed Outreach and Patient Navigation for Colorectal Cancer Screening Among Rural Medicaid Enrollees: A Cluster Randomized Clinical Trial.针对农村医疗补助计划参保者的结直肠癌筛查邮件外展与患者导航服务:一项整群随机临床试验
JAMA Netw Open. 2025 Mar 3;8(3):e250928. doi: 10.1001/jamanetworkopen.2025.0928.
6
Interval Colorectal Cancers in a Fecal Immunochemical Test-Based Screening Program.基于粪便免疫化学检测的筛查项目中的间隔期结直肠癌
JAMA Netw Open. 2025 Jul 1;8(7):e2523441. doi: 10.1001/jamanetworkopen.2025.23441.
7
Centralized Colorectal Cancer Screening Outreach in Federally Qualified Health Centers: A Randomized Clinical Trial.在联邦合格健康中心开展集中结直肠癌筛查外展活动:一项随机临床试验。
JAMA Netw Open. 2024 Nov 4;7(11):e2446693. doi: 10.1001/jamanetworkopen.2024.46693.
8
Multilevel intervention for follow-up of abnormal FIT in the safety-net: IMProving Adherence to Colonoscopy through Teams and Technology (IMPACTT).安全网中粪便免疫化学检测异常的多级随访干预:通过团队和技术提高结肠镜检查的依从性(IMPACTT)。
Contemp Clin Trials. 2025 Mar;150:107810. doi: 10.1016/j.cct.2025.107810. Epub 2025 Jan 12.
9
Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.粪便免疫化学检测用于在初级保健中对有下腹部症状的患者进行分流,以确定是否需要转诊疑似结直肠癌患者:一项系统评价和成本效益分析。
Health Technol Assess. 2017 May;21(33):1-234. doi: 10.3310/hta21330.
10
Comparative Performance of Common Fecal Immunochemical Tests : A Cross-Sectional Study.常见粪便免疫化学检测的比较性能:一项横断面研究。
Ann Intern Med. 2024 Oct;177(10):1350-1360. doi: 10.7326/M24-0080. Epub 2024 Sep 3.

本文引用的文献

1
Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening.邮寄粪便免疫化学试验对新符合结直肠癌筛查条件患者的影响。
Dig Dis Sci. 2023 Jun;68(6):2315-2317. doi: 10.1007/s10620-023-07925-1. Epub 2023 Mar 25.
2
Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.OC-Light 便潜血免疫化学法检测阳性后的结肠镜检查的检出率。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1593-1597.e1. doi: 10.1016/j.cgh.2018.04.014. Epub 2018 Apr 13.
3
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.
粪便检测结果呈阳性后至结肠镜检查的时间与结直肠癌风险及诊断时癌症分期之间的关联。
JAMA. 2017 Apr 25;317(16):1631-1641. doi: 10.1001/jama.2017.3634.